Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 23Peritoneal Neoplasms 15Fallopian Tube Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 6Carcinoma, Ovarian Epithelial 5Neoplasms 3Sarcoma 2Rhabdomyosarcoma 2Recurrence 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Brain Neoplasms 2Appendiceal Neoplasms 2Adrenocortical Carcinoma 2Adenoma, Islet Cell 2Wilms Tumor 1Retroperitoneal Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Postoperative Complications 1Peritoneal Cavity Cancer 1Peritoneal Cancer 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neuroblastoma 1

Interventions

Gastrectomy 4Taxes 3sintilimab 2S 1 (combination) 2Paclitaxel 2Oxaliplatin 2Hyperthermic Intraperitoneal Chemotherapy 2Drug Therapy 2Cisplatin 2Albumin-Bound Paclitaxel 2trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1tipiracil 1taxane 1pembrolizumab 1durvalumab 1disitamab vedotin 1cabozantinib 1apatinib 1XELOX 1Trifluridine 1Tegafur 1Tadalafil 1SHR-1701 1Resistance Training 1Radiotherapy 1Platinum 1Magnetic Resonance Spectroscopy 1Irinotecan 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastric Adenocarcinoma × Cytoreduction Surgical Procedures × Clear all
NCT07178808 2026-05-01

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

Banner Health

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡